Boxer Capital LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 4:31 pm Sale | 2024-01-23 | 13D | Mirati Therapeutics, Inc. MRTX | Boxer Capital LLC | 0 0.000% | -11,661,726 (Position Closed) | Filing |
| 2023-10-12 1:07 pm Unchanged | 2023-10-08 | 13D | Mirati Therapeutics, Inc. MRTX | Boxer Capital LLC | 11,661,726 15.900% | 0 (Unchanged) | Filing |
| 2023-08-16 4:28 pm Purchase | 2023-08-11 | 13D | Mirati Therapeutics, Inc. MRTX | Boxer Capital LLC | 11,661,726 15.900% | 1,370,879 (+13.32%) | Filing |
| 2020-10-30 9:44 pm Purchase | 2020-10-28 | 13D | Mirati Therapeutics, Inc. MRTX | Boxer Capital LLC | 10,290,847 18.900% | 1,522,564 (+17.36%) | Filing |